You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
特一藥業(002728.SZ):當前核心產品止咳寶片銷售佔比較高 對經營業績影響較大
格隆匯 05-23 15:07

格隆匯5月23日丨有投資者在投資者互動平台向特一藥業(002728.SZ)提問,“貴公司一季度業績值的投資者點贊!!!請問公司二季度開始至今,生產與銷售是否滿產滿銷?公司藥品特別是止咳寶片庫存是否在安全線以內? ”

特一藥業(002728.SZ)回覆稱,公司第一季度業績增長較好主要是因為公司止咳退燒等相關產品恢復性增長較快,特別是公司核心產品特一止咳寶片在知名度進一步提高的情況下,公司止咳寶片等相關藥品銷售的大幅增長帶來了經營業績持續的增長。當前,公司核心產品止咳寶片的銷售佔比較高,對公司經營業績的影響較大。止咳寶片有一百多年曆史,在清代末期就享有盛譽,具有“宣肺祛痰、止咳平喘”之功效。經臨牀總結有三大特點:一是對各類型的慢性咳嗽有顯著效果,對止咳、化痰、平喘療效十分明顯,臨控+顯效率為 73%,總有效率為 93%;二是毒副作用低,療程短、見效快、服藥方便;三是對虛寒型和痰濕型咳喘治療效果最好,總有效率分別是 100%及 95%。公司目前正滿負荷生產市場所需產品,保障市場供應。公司目前正在逐步實現產品庫存,以達到安全儲備以備不時之需。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account